Evidence map›Paper›PMID 40830875›Full record

ArticleMicrobial cell factories2025

Green synthesis of silver nanoparticles (AgNPs) from G. stearothermophilus GF16: stable and versatile nanomaterials with antioxidant, antimicrobial, and catalytic properties.

Alessia Di Fraia, Giovanni Dal Poggetto, Michela Salamone, Federica Carraturo, Patrizia Contursi, Marco Guida, Danila Limauro, Viviana Scognamiglio, Manuela Rossi, Gabriella Fiorentino

Abstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alessia Di FraiaDepartment of Biology, University of Naples Federico II, Naples, Italy.
Giovanni Dal PoggettoInstitute of Polymers, Composites and Biomaterials, National Research Council, Pozzuoli, Italy.
Michela SalamoneDepartment of Biology, University of Naples Federico II, Naples, Italy.
Federica CarraturoDepartment of Biology, University of Naples Federico II, Naples, Italy.
Patrizia ContursiDepartment of Biology, University of Naples Federico II, Naples, Italy.
Marco GuidaDepartment of Biology, University of Naples Federico II, Naples, Italy.
Danila LimauroDepartment of Biology, University of Naples Federico II, Naples, Italy.
Viviana ScognamiglioInstitute of Crystallography, Department of Chemical Sciences and Materials Technology, National Research Council, Rome, Italy.
Manuela RossiDepartment of Earth Sciences, Environment and Resources, University of Naples Federico II, Naples, Italy.
Gabriella FiorentinoDepartment of Biology, University of Naples Federico II, Naples, Italy. fiogabri@unina.it.

Funding

Ministero dell'Università e della Ricerca, PRIN 2022 AGRI-FOOD CHIP Agri-food CHains Integration Project. E53C24003120006
6 · The paper itself

Abstract

backgroundSilver nanoparticles (AgNPs) have attracted considerable interest for their distinctive physicochemical properties and wide-ranging applications in nanomedicine, environmental catalysis, and antimicrobial applications. However, sustainable and robust biosynthesis methods remain a challenge.

resultsIn this study, we report the biosynthesis of thermostable AgNPs using the secretome of Geobacillus stearothermophilus GF16, a thermophilic and metal-resistant bacterium isolated from the hydrothermal volcanic area of Pisciarelli, Italy. The synthesis was performed without specialized growth media, relying solely on the cell-free bacterial supernatant, and was systematically optimized by varying precursor concentration, temperature, pH, and reaction time. The nanoparticles were characterized by UV-Vis spectroscopy, dynamic light scattering, Fourier-transform infrared spectroscopy, scanning (SEM) and transmission (TEM) electron microscopy. Morphological analysis showed predominantly subspherical nanoparticles with average diameters of 17 ± 5 nm (SEM) and 16 ± 5-7 nm (TEM), depending on precursor concentration. Thermogravimetric analysis demonstrated excellent thermal stability with retention of structural integrity up to 120 °C, an exceptional feature among biogenic AgNPs. The obtained AgNPs exhibited remarkable radical scavenging activity, reaching up to 79% in DPPH and 75% in ABTS assays at 100 µg/mL, highlighting a level of antioxidant performance rarely observed in AgNPs of bacterial origin. In addition to their redox properties, the nanoparticles demonstrated efficient catalytic activity as evidenced by the complete degradation of Congo Red in 20 min and 4-nitrophenol in 35 min. Time-kill assays and minimum inhibitory concentration (MIC) also showed a broad-spectrum antimicrobial potential with complete inhibition of Staphylococcus aureus, Pseudomonas aeruginosa, and Salmonella Typhimurium at 100 µg/mL. Interestingly, MIC values were significantly lower than those reported for comparable AgNPs. Notably, the nanoparticles also displayed hemocompatibility, validated by hemolysis assays performed on both healthy and β-thalassemic erythrocytes, with hemolysis rates consistently below the 2% safety threshold.

conclusionsOverall, this study presents the first comprehensive characterization of AgNPs biosynthesized by a thermophilic bacterium, highlighting their multifunctional potential. The use of a thermophilic bacterium as a robust and flexible microbial nanofactory offers a novel eco-friendly and scalable strategy for AgNP production. The resulting nanoparticles exhibit unique thermal stability, broad-spectrum bioactivity, and clinically relevant hemocompatibility, underscoring their promising applicability in nanomedicine, green catalysis, and environmental remediation.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsAntioxidantsGeobacillus stearothermophilusGreen Chemistry TechnologyMetal NanoparticlesSilverCatalysisMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsAntioxidantsSilverAntimicrobial activityBiocompatibilityCatalytic efficiencyExtremophilesNanofactorySilver nanoparticles

Identifiers

PMID40830875
PMCPMC12362984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.